IceCure Medical, an Israeli company developing a minimally invasive medical device for treating tumors, recently announced that it will start offering its technology, called cryoablation, in Israel in upcoming weeks.
The company’s device is an ultrasound imaging-guided probe that injects liquid nitrogen into a tumor and does not require hospitalization, leaves minimal to no scarring, and has a short recovery time. Destroyed tumor cells are then reabsorbed in the body over time.
The treatment, which is approved in the US and the European Union, will be available in Israel to women suffering from fibroadenomas, benign breast tumors usually found in women under 30, and for patients with malignant kidney tumors.
Article excerpts from calcalisttech.com
For the estimated 250 million people worldwide who suffer from rare diseases, there is little hope for diagnosis or treatment. Because each individual disease impacts so few people, hardly any funding is allocated to research, leaving many without medical options.
A 57-year-old man who used to blow the shofar in his synagogue until he was 17, when he suffered serious lung damage in a prank played on him, succeeded in blowing the ram's horn again for the first time.
For many women who have difficulty getting pregnant, the in vitro fertilization (IVF) process can be extremely stressful and all consuming.